ABOUT THIS EPISODE
ACOG updated its menopause treatment guidelines for the first time since 2014, and several old assumptions didn't survive the revision. This episode also covers a new systematic review on non-hormonal treatments for depression and anxiety during perimenopause and postmenopause, and a strengthened ACOG recommendation that more midlife women should know about before they go into surgery.
Key Takeaways:
• ACOG's 2026 guidelines update is the first since 2014 and explicitly strengthens support for hormonal therapy for women under 60 or within 10 years of menopause onset who don't have contraindications.
• The "hormones or suffer" binary is a myth: a 2026 systematic review found several non-hormonal medications — including certain antidepressants and gabapentin — have meaningful evidence for menopause-related depression and anxiety.
• Non-hormonal options are not all equal; the review found wide variation in how well individual drugs performed, and "non-hormonal" does not automatically mean low-risk or side-effect-free.
• ACOG now recommends that doctors discuss removing the fallopian tubes — not just the ovaries — during unrelated pelvic surgeries, because most ovarian cancers actually start in the fallopian tubes.
• Removing only the fallopian tubes during another surgery reduces ovarian cancer risk without triggering surgical menopause, which is a meaningfully different outcome than removing the ovaries.
Sources & References:
• Efficacy and safety of non-hormonal pharmacotherapies for depressive and anxiety symptoms during the menopausal transition and postmenopause: a systematic review (https://pubmed.ncbi.nlm.nih.gov/42902266/) - PubMed
• Hot flashes, night sweats, insomnia – OB-GYNs set new rules for menopause treatment (https://www.npr.org/2026/10/16/nx-s1-6005201/health-treatment-menopause-hot-flash-night-sweats-insomnia) - NPR Health
Listen with full show notes: https://hotflasher.com/episodes/2026-10-21-myth-busting
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
Key Takeaways:
• ACOG's 2026 guidelines update is the first since 2014 and explicitly strengthens support for hormonal therapy for women under 60 or within 10 years of menopause onset who don't have contraindications.
• The "hormones or suffer" binary is a myth: a 2026 systematic review found several non-hormonal medications — including certain antidepressants and gabapentin — have meaningful evidence for menopause-related depression and anxiety.
• Non-hormonal options are not all equal; the review found wide variation in how well individual drugs performed, and "non-hormonal" does not automatically mean low-risk or side-effect-free.
• ACOG now recommends that doctors discuss removing the fallopian tubes — not just the ovaries — during unrelated pelvic surgeries, because most ovarian cancers actually start in the fallopian tubes.
• Removing only the fallopian tubes during another surgery reduces ovarian cancer risk without triggering surgical menopause, which is a meaningfully different outcome than removing the ovaries.
Sources & References:
• Efficacy and safety of non-hormonal pharmacotherapies for depressive and anxiety symptoms during the menopausal transition and postmenopause: a systematic review (https://pubmed.ncbi.nlm.nih.gov/42902266/) - PubMed
• Hot flashes, night sweats, insomnia – OB-GYNs set new rules for menopause treatment (https://www.npr.org/2026/10/16/nx-s1-6005201/health-treatment-menopause-hot-flash-night-sweats-insomnia) - NPR Health
Listen with full show notes: https://hotflasher.com/episodes/2026-10-21-myth-busting
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
Three new papers landed this week, and they're all quietly about cardiovascular risk in postmenopausal women — from how we read heart scans, to how dietary fat affects cholesterol and gut health, to why doctors still aren't getting enough training on menopause. This episode breaks down what the res…
A large new study reveals that hormonal change during menopause isn't gradual — it drops sharply right at the final period, which may reshape how we think about timing treatment. This episode also covers a lifespan look at metabolic health and menopause, and a rare but important case report about w…
This episode covers new research linking early menopause to higher cognitive risk, a 12-month study showing HRT reduces hand joint pain in perimenopausal women, and a USA Today look at whether pairing scientists with social media influencers is a real solution to menopause misinformation.
Key Take…
This episode covers a USA Today investigation into FDA warnings about UTIs turning fatal in menopausal women, a major global study finding women report more pain than men with the sharpest rise happening before age 55, and a controversy in Spain over an official menopause guide built almost entirel…
This episode covers three things perimenopausal women deal with constantly but don't always get good answers on: gut changes, weight gain, and how to actually stick with strength training. Nykki pulls from a Harvard gastroenterologist's conversation about the gut-hormone connection, a Toronto Star …
Disclaimer: The podcast and artwork embedded on this page are from Hot Flasher, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
